NCT00249483View on ClinicalTrials.gov

Venlafaxine to Reduce Cocaine Dependence in Depressed Individuals

PHASE2CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 31, 1999

Primary Completion Date

February 28, 2005

Study Completion Date

February 28, 2005

Conditions
Cocaine-Related Disorders
Interventions
DRUG

Venlafaxine

Venlafaxiine 300mg/day

DRUG

Placebo

Placebo

Trial Locations (1)

10032

New York State Psychiatric Institute, New York

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

New York State Psychiatric Institute

OTHER

NCT00249483 - Venlafaxine to Reduce Cocaine Dependence in Depressed Individuals | Biotech Hunter | Biotech Hunter